tldrdailynews.com logo

"Biomedicines' Generative AI Pipeline Secures $273M in Series C Financing"

1 min read
Source: STAT
"Biomedicines' Generative AI Pipeline Secures $273M in Series C Financing"
Photo: STAT
TL;DR

Biotech startup Generate Biomedicines has raised $273 million in a Series C funding round, with investors including Amgen and NVIDIA. The company uses artificial intelligence and machine learning algorithms to identify new drugs, and has already launched its first clinical trial for a Covid monoclonal antibody. Generate Biomedicines plans to introduce 10 new drug candidates annually and has a total of 15 drug candidates in the works.

Topics:businessbiotechhealthcare#artificial-intelligence#biotech#biotechhealthcare#drug-discovery#funding#machine-learning
Share this article
  1. Generate Biomedicines machine learning biotech raises $273M  STAT
  2. Generate raises huge $273M series C, but it's also a down round  FierceBiotech
  3. Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics  Business Wire
  4. View Full Coverage on Google News

Want the full story? Read the original reporting

Read on STAT